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Evaluation of lower urinary system symptoms
and neurogenic bladder in children with
cerebral palsy: relationships with the severity
of cerebral palsy and mental status
Aim: This study aimed to evaluate lower urinary system symptoms, to determine bladder type in
children with cerebral palsy (CP), and to determine the relationship between bladder type, and the
severity of CP and mental status of the children.
Materials and Methods: The study included 41 children with CP. Subjects were first asked to provide
information concerning lower urinary system symptoms. Urodynamic examination was performed in
41 children with CP. The severity of CP was determined according to the Gross Motor Functional
Classification System (GMFCS). The Stanford-Binet Intelligence Scale was used to determine
intelligence quotients (IQ). After urodynamic examination, subjects were divided into 2 groups based
on bladder type: neurogenic detrusor overactivity (NDO) and normal bladder (NB) groups.
Results: One or more lower urinary system symptoms were observed in 78% of the subjects. NDO was
observed in 30 subjects (73.2%), while NB was observed in 11 (26.8%), based on urodynamic study.
While there was an almost statistically significant difference in terms of IQ scores (P = 0.053) between
the NDO and NB groups, there was not a statistical difference in terms of GMFCS distribution.
Conclusion: The incidences of urinary system symptoms and neurogenic bladder are high in the CP
population. Multiple factors, such as the effects on IQ, bladder functions, and mobility caused by
cerebral lesions, may cause urinary dysfunction.
Key words: Cerebral palsy, lower urinary system symptoms, neurogenic bladder, mental status,
disability

Serebral palsili çocuklarda alt üriner sistem semptomlarinin ve
nörojenik mesanenin değerlendirilmesi: serebral palsinin şiddeti ve
çocuğun mental durumu ile ilişkisi
Amaç: Çalışmanın amacı serebral palsili (SP) çocuklarda alt üriner system semptomlarını
değerlendirmek, mesane tipini belirlemek ve mesane tipinin SP’nin şiddeti ve SP’li çocuğun mental
durumu ile ilişkisini ortaya koymaktır.
Received: September 24, 2008
Accepted: April 02, 2009

Hastalar ve Yöntemler: 41 SP’li çocuk çalışmaya alındı. Olgular öncelikle alt üriner system semptomları
yönünden sorgulandı. 41 olguya ürodinamik inceleme yapıldı. SP’nin şiddeti Kaba Motor Fonksiyonel
Sınıflama Sistemi (KMFKS) ile değerlendirildi. Olguların zeka bölümünü değerlendirmede StanfordBinet Zeka Skalası kullanıldı. Ürodinamik incelemeden sonra olgular mesane tipine göre aşırı aktif
nörojenik detrüsor (AAND) ve normal mesane (NM) olarak iki gruba ayrıldı.

Sibel ÜNSAL DELİALİOĞLU

Bulgular: Olguların % 78’inde bir ya da daha fazla alt üriner sistem semptomu saptandı. 30 (% 73,2)
olguda AAND ve 11 (% 26,8) olguda NM saptandı. AAND ve NM grupları arasında zeka bölümü
açısından istatistiksel olarak anlamlı olabilecek fark saptanırken KMFKS dağılımları açısından fark
saptanmadı.

Miralay Nazımbey Sokak,
No: 145/7,
06170 Yenimahalle,
Ankara - TURKEY

Sonuç: SP populasyonunda alt üriner sistem semptomları ve nörojenik mesane insidansı yüksektir.
Serebral lezyona bağlı olarak zeka bölümü, mesane fonksiyonları ve mobilite gibi çeşitli faktörler üriner
disfonksiyona neden olabilir.
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Introduction
Cerebral palsy (CP) describes a group of
permanent disorders of the development of
movement and posture, causing activity limitation,
that are attributed to non-progressive disturbances
that occurred in the developing fetal or infant brain.
The motor disorders of CP are often accompanied by
disturbances in sensation, perception, cognition,
communication, and behavior, and by epilepsy and
secondary
musculoskeletal
problems
(1).
Neurological damage in CP may cause delayed or
incomplete development of bladder control, and can
also cause impairment in communication, cognition,
upper arm function, and mobility. Both neurological
damage and impairment may result in urinary
incontinence (2). Urinary incontinence, or enuresis,
is common among adults and children with CP (2-4);
however, the actual incidence of incontinence in CP is
not precisely known. Early studies demonstrated that
at least one-third of children with CP have 2 or more
types of lower urinary system symptoms (4). Bladder
capacity increases over time in normal children and
plays an important role in the development of urinary
continence (5). Studies conducted in this area report
that bladder capacity decreases with detrusor
hyperreflexia in CP (3,6). It is thought that the
uninhibited contractions from detrusor hyperreflexia
make urinary continence difficult to obtain (7). The
ability to void or inhibit voiding voluntarily at any
degree of bladder filling commonly develops during
the second and third years of life, and most children
acquire an adult pattern of urinary control by the age
of 4 years (8). Furthermore, the age at which bladder
control is achieved in children with CP is higher than
that in their healthy peers (2,9). Although lower
urinary tract symptoms and related urodynamic
findings in this group of patients have been
documented in several studies (2-4,6,7), the
relationships between neurogenic bladder, mental
functions, and the severity of CP have not been
evaluated adequately.
Most researchers agree that the bladder pathology
associated with neurological damage can be observed
when an urodynamic study is performed on subjects
with lower urinary system symptoms (10).
Introduction of appropriate treatment protocols after
determining the causes of urinary system symptoms
will be an important step in the rehabilitation of CP
patients.
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The aim of the present study was to investigate
lower urinary system symptoms in children with CP,
to determine their bladder type, and to determine the
relationship between bladder type, and the severity of
CP and mental status of the children.
Methods
Subjects
The study included 60 children with CP. The
subjects’ relatives were informed about the
examination, and their written informed consent for
the study were obtained. The study protocol was
approved by the local ethics committee. The subjects
were first examined with respect to lower urinary
system symptoms, and thereafter further planning
was made for urodynamic examination of all the
subjects.
It was possible to perform a urodynamic
examination in only 41 subjects that were able to fully
cooperate; therefore, 19 subjects were excluded. All
the subjects with CP were diagnosed by a pediatric
neurologist. A detailed systematic physical and
neuromuscular system examination was performed
for each subject included in the study in order to
determine CP type according to the clinical
classification (11,12). The subjects were investigated
as to whether they were able to express their urination
need or not, and the age they were able to state their
needs was recorded as the expression age in months.
Common lower urinary system symptoms, such as
day-time incontinence, night-time incontinence, dayand night-time incontinence, stress incontinence,
urgency, frequency, difficulty initiating voiding, and
recurrent urinary system infections were investigated
in detail (3,7). A minimum of one instance of
incontinence a night was recorded as night-time
incontinence, while a minimum of one instance of
incontinence during a day was accepted as day-time
incontinence. Stress incontinence was defined as
involuntary leakage on effort or exertion, or when
sneezing or coughing. Urgency was defined as a
sudden compelling desire to pass urine that is difficult
to defer (13).
Instruments
Kidney functions were evaluated by examining
serum urea, creatinine, sodium, potassium,
phosphorus, and uric acid levels. Urinary tract
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infections were investigated through urinalysis, urine
culture, blood leucocyte count, erythrocyte
sedimentation, and C-reactive protein tests.
Pathological changes in the kidneys, the ureters, and
the bladder were assessed using urinary system
ultrasonography. Urodynamic examination was
performed in 41 children with CP that had normal
kidney function test results, did not have clinical or
laboratory urinary tract infections, did not have any
pathology of the urinary system based on
ultrasonography, and were able to cooperate.
Subjects were not sedated before urodynamic
examination because of the possible effects of sedation
on detrusor function. Urodynamic examination,
consisting
of
cystometry
and
sphincter
electromyography (EMG), was performed using a
Libra (MMS, Enschede, The Netherlands)
urodynamic measuring system and a 6F doublelumen transurethral urodynamic catheter. A rectal
ball catheter was placed in the rectum in order to
measure abdominal pressure. A surface electrode was
placed around the anal region to record sphincter
EMG. Sodium chloride solution (0.9%) at room
temperature was used to fill the bladder at a rate of 20
mL min−1 after discharging all the urine in the
bladder. Filling was discontinued when the subject
indicated bladder fullness or when significant leakage
occurred. During the filling procedure, subjects were
kept in the supine position. The level at which
significant urination or leakage occurred, or at which
intravesical pressure exceeded 40 cm H2O was defined
as cystometric capacity. Upon completion of the
urodynamic study, bladder types were determined on
the basis of bladder capacity and bladder pressure.
Detrusor-sphincter dyssynergia was investigated by
voiding cystometry performed together with
sphincter EMG.
Expected normal bladder capacity for each subject
was calculated according to a formula developed for
normal children: bladder capacity = [(age/2) + 6] ×
28 (mL)] (14). All methods and definitions were
based on the International Continence Society (13).
The term neurogenic detrusor overactivity (NDO)
was used instead of detrusor hyperreflexia. The
subjects were then divided into 2 groups: those with
NDO and those with a normal bladder (NB) on the
basis of urodynamic examination results.
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The severity of CP was determined according to
the Gross Motor Functional Classification System
(GMFCS) (15). GMFCS is a standardized measure
that classifies gross motor functions in children with
CP. It is a 5-level system defined by separating 4 age
groups. In particular, it emphasizes sitting and
walking functions of children, focusing on selfinitiation of the action. Children in level I are very
independent in motor functions, while those in level
V are the least independent. Level I: walks without
restrictions; II: walks without assistive devices,
limitations in walking outdoors; III: walks with
assistive devices; IV: self-mobility with limitations,
children are transported or use powered mobility; V:
self-mobility is severely limited (15,16). Patients with
GMFCS level 1-2 were classified as mild, those with
level 3 were classified as moderate, and those with
level 4-5 were classified as severe CP (GMFCS
groups).
In order to determine the intelligence quotients
(IQ) of the subjects, an evaluation was performed by
a psychologist using the Stanford-Binet Intelligence
Scale, devised by Terman and Merill (17). This scale
was previously adapted for use with Turkish children
by Ugurel-Semin (18). According to the test, those
with scores of 160-140 are classified as genius, 139120 as superior, 119-110 as medium high, 109-90 as
normal, 89-80 as low middle, 79-70 at the boundary of
retardation, and ≤ 69 as mentally retarded (17).
Statistics
Statistical analysis of the collected data was
performed using SPSS v.11.0. Descriptive statistics
were used to express results. Subjects were divided
into 2 groups (NDO and NB) after urodynamic
examination. Distribution of lower urinary system
symptoms and GMFCS levels in these groups were
compared using the chi-square test. Independent
samples t-test was used to determine whether there
were any differences between the NDO and NB
groups with respect to measured and expected
bladder capacities, and IQ scores. Logistic regression
analysis was performed in order to predict the
neurogenic bladder state based on IQ scores, the age
when they were able to express their urination need,
and the severity of CP.
573
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Results
The study included 41 subjects (16 girls (39%) and
25 boys (61%)), with mean age of 8.09 ± 2.96 years.
In all, 21 children (51.2%) had spastic diplegic CP, 11
(26.8%) had spastic quadriplegic CP, 7 (17.1%) had
mixed types, and 2 (4.9%) had right hemiplegic CP.
In terms of the severity of CP, 28 (68.3%) subjects had
moderate (GMFCS level 3) and 13 (31.7%) had severe
(GMFCS level 4-5) CP. Percentages of lower urinary
system symptoms in all subjects are shown in Table 1.
NDO was observed in 30 subjects (73.2%), while
NB was observed in 11 (26.8%) based on urodynamic
examination. Neither reflex detrusor nor detrusorsphincter dyssynergia was detected in any of the
subjects. The 30 subjects with NDO included 11 girls
and 19 boys with mean age of 7.60 ± 2.40 years,
whereas the 11 subjects with NB included 5 girls and
6 boys with mean age of 9.45 ± 3.95 years. A
statistically significant difference in terms of gender
(X2 = 0.220, P = 0.881) and mean age (t = −1.826, P =
0.076) between the NDO and NB groups was not
observed. Of the subjects with NDO, 19 (63.3%) had
spastic diplegic CP, 7 (23.3%) had spastic quadriplegic
CP, and 4 (13.3%) had mixed-type CP. Of the subjects
with NB, 4 (36.4%) had spastic quadriplegic CP, 3
(27.3%) had mixed-type CP, 2 had (18.2%) spastic
diplegic CP, and 2 (18.2%) had right hemiplegic CP.
Due to an insufficient number of subjects in each
group, the relationship between CP type and bladder
type was not investigated.

Table 1.

Thirty-one (75.6%) of the 41 subjects had at least
1 lower urinary system symptom, while 10 (24.4%)
had no lower urinary symptoms (2 in the NDO group
and 8 in the NB group). The distribution of lower
urinary system symptoms according to bladder type is
given in Table 1. A significant difference was observed
between the groups with respect to stress
incontinence and frequency complaints (respectively
X2 = 7.942, P = 0.005; X2 = 4.072, P = 0.044). While
73.3% of the NDO group had stress incontinence and
50% had frequency complaints, only 18.2% of the NB
group had stress incontinence and 9.1% had
frequency complaints.
A significant difference was not observed between
the groups in terms of expressing the need to urinate
(t = 0.673, P = 0.505). Mean age at which the need to
urinate was verbalized was 45.80 ± 22.58 months in
the NDO group and 40.90 ± 13.36 months in the NB
group.
Mean bladder capacity in the NDO group (148.73
± 58.69 mL) was significantly lower (t = 4.215, P =
0.000) than that in the NB group (231.36 ± 45.52 mL).
The difference (P = 0.067) between the NDO (271.86
± 30.89) and NB groups (297.36 ± 54.56) with respect
to mean value of expected bladder capacity was not
statistically significant.
In all, 21 patients (51.2%) in the NDO group had
moderate CP and 9 patients (22%) had severe CP. In
the NB group 7 patients (17.1%) had moderate CP
and 4 patients (9.8%) had severe CP. There was no

Observed frequencies of lower urinary system symptoms in all subjects with CP and the distribution of lower urinary system
symptoms according to the bladder type.

Urological Symptoms

Day-time incontinence
Night-time incontinence
Day- and night-time incontinence
Stress incontinence
Urgency
Frequency
Difficulty initiating voiding
*Significant.
NDO: Neurogenic detrusor overactivity.
NB: Normal bladder.
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All Subjects
(n = 41)

NDO (%)
(n = 30)

NB (%)
(n = 11)

P

14.6
19.5
22
58.5
29.3
39
14.6

20
26.7
30
73.3
30
50
0

0
0
0
18.2
27.3
9.1
0

0.268
0.143
0.103
0.005*
1.000
0.044*
-
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difference between the 2 groups in terms of GMFCS
2
groups (moderate and severe groups) (X = 0.000, P =
0.993).
One of the 2 subjects (4.9%) with IQ scores
between 90 and 109 had NDO and the other had an
NB, as did the 2 subjects with IQ scores between 80
and 89, and with the same distribution. Five of the 8
subjects (19.5%) with IQ scores between 70 and 79
had NDO and 3 had an NB, while the same figures
were, respectively, 23 (NDO) and 6 (NB) among the
29 subjects (70.7%) with IQ scores ≤ 69. There was an
almost statistically significant difference in IQ scores
(t = -1.998, P = 0.053) between the NDO (61.61 ±
2.65) and NB (70.36 ± 11.62) groups.
Logistic regression analysis was used in order to
determine if age at which the need to urinate was first
expressed, IQ score, and the severity of CP (GMFCS
group 1 and group 2) were significantly related to
bladder type. IQ scores and the age at which the need
to urinate was first expressed took place in this model.
The classification scale of the model, based on the
logistic regression analysis applied to the related
scores, is given in Table 2. When the classification
table was evaluated it was correctly predicted that
36.4% of the subjects were in the NB group and 93.3%
of the subjects were in the NDO group. The rate of
correct classification of the model according to this
scale was 78%. The X2 value of the model was 8.708
and this value was statistically significant (P = 0.033).
According to the results of this analysis, the age at
which the need to urinate was first expressed (P =
0.044) would make the classification of bladder type
Table 2.

August 2009

easier; however, the results indicate that the severity of
CP (P = 0.773) and IQ score (P = 0.078) were not
significant in the prediction of bladder type.
Discussion
More than one-third of children with CP present
with dysfunctional urinary symptoms (4). In the
present study, 1 or more lower urinary system
symptoms were observed in the 78% of the subjects
and the most frequently observed symptoms
(consistent with the literature) were stress
incontinence, and frequency and urgency complaints
(3,4,7). Karaman et al. showed that 66.6% of 36
children with CP had dysfunctional voiding
symptoms (19). Decter et al. observed incontinence
complaints in 86% of 57 subjects with CP that
presented with urological symptoms (7). Early studies
demonstrated that the most common symptoms in
subjects with CP presenting with lower urinary
system complaints were incontinence, frequency,
urgency, stress incontinence, and difficulty in
initiating voiding (3,4,20). The results of our study
and the literature show that children with CP should
be questioned carefully in terms of lower urinary
system symptoms.
Ewalt and Bauer suggest that careful clinical and
radiological evaluation is necessary in children with
CP that present with voiding problems (21). Brodak et
al. concluded that when there is the absence of a
urinary tract infection and lower urinary tract
symptoms, it is unnecessary to evaluate these patients

Prediction of the neurogenic bladder state based on the age at which the need to urinate was first expressed, intelligencequotient (IQ), and the severity of CP.
Predicted Group
Bladder Status
Correctness of Estimate (%)

Observed Group
Bladder
Status

NB
NDO

Total (%)

NB

NDO

4
2

7
28

36.4
93.3
78.0

NB: Normal bladder.
NDO: Neurogenic detrusor overactivity.
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for neurogenic bladder dysfunction (10). As such, in
a recent study by Bross et al. (22) it was concluded that
urodynamic assessment should be performed in all
children with infantile CP and that the decision
should not be based on clinical symptoms, such as
recurrent urinary tract infection or urinary
incontinence. As a matter of fact, we performed
urodynamic examinations in children with and
without lower urinary system symptoms. Although
we observed higher rates of NDO in subjects with
lower urinary system symptoms, we also observed
NDO in asymptomatic subjects.
In the present study NDO was observed in 30 of
the 41 subjects and NB was observed in 11 subjects.
Reflex detrusor or detrusor-sphincter dyssynergia was
not observed in any of the subjects included in the
study. Based on urodynamics, Decter et al. reported
that the most common abnormality was NDO (70%)
and that 7 patients (12%) had detrusor-sphincter
dyssynergia (7). This leads us to conclude that NDO
is common in children with CP. Uninhibited bladder
contractions resulting from detrusor hyperreflexia
cause urinary continence to be difficult (23). High
level of stress incontinence in the children with NDO
and the existence of frequency symptoms in the
present study may have been due to overactive
contraction of the hyperreflex detrusor muscle.
Bladder capacity increases over time in normal
children and has an important role in the
development of urinary continence (5). Studies have
reported that bladder capacity decreases with detrusor
hyperreflexia in CP (3,6). In the present study bladder
capacity in the subjects with NDO, as measured by
urodynamic examination, was significantly lower
than that in the NB group, leading us to think that
decreased bladder capacity, along with detrusor
hyperreflexia, is another factor contributing to
retardation of urinary continence in children with CP.
Hyperreflexia and reduced bladder capacity can be
considered as findings of the upper motor neuron
lesions leading to CP. Although upper motor neuron
damage is observed in most children with CP, there
are also reported cases of lower motor neuron lesions
and vesicoureteral reflux (1,24).
Autonomic nerve system maturation and the
functions of frontal and parietal lobes, in addition to
urinary system maturation, also affect the
development of bladder control (2). Normal children
576
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achieve day-time continence at the age of 2 or 3 years
(11). Ninety-five percent of normal children by the
age of 5 years achieve day-time continence, while
80%-85% achieve night-time continence (25). It is
reported that children with CP achieve urinary
continence later than their normal counterparts (2).
Ozturk et al. compared continence rates of patients
with CP (n = 45) to those of healthy children (n = 37).
Mean age for nighttime bladder control was 47
months for children with CP and 27 months for
healthy children, indicating that bladder control is
delayed in patients with CP (8). In Turkey, Erkin et al.
evaluated the functional disability of Turkish children
with CP using the Functional Independence Measure
of Children (WeeFIM) and reported that the
sphincter control subset scores increased in children
with CP as they aged, whereas in healthy controls such
a change was not observed (26). In the present study
we observed that most of the subjects were
incontinent, even though they could express the need
to urinate. It was also determined that the NDO group
began to express the need to urinate later than those
in the NB group. This finding indicates that the effect
on bladder functions caused by cerebral lesion
damage in CP is an important factor in delayed
attainment of urinary continence.
It is also suggested that many factors affect bladder
control attainment in children with CP. Borzyskowski
argues that age, mobility, and cognitive functions may
affect bladder control, and that the situation does not
arise only from a relationship between the evaluated
bladder function and the central nervous system (24).
Roijen et al. divided subjects with CP into 2 groups of
low and high intellectual capacity, according to their
intellectual capacity on the basis of school types to
which they attended (2). They reported that
tetraplegic patients with low intellectual capacity
achieved urinary continence at a later age than did
diplegic and hemiplegic CP patients with higher
intellectual capacity. Lower IQ levels, though almost
statistically significant, of the subjects with NDO in
our study suggest that both bladder dysfunction and
cognitive functions may influence the achievement of
urinary continence in children with CP. As a result,
lesions in the central nervous system that cause CP in
these subjects lead to neurogenic bladder and
adversely affect cognitive functions. Urinary
incontinence may be present in children with CP that

Vol: 39

No: 4

Neurogenic Bladder in Cerebral Palsy

also have the cognitive ability for toilet training;
however, there may be patients that cannot be toilet
trained due to insufficient cognitive capacity, despite
of the absence of a neurogenic bladder. Therefore, in
clinical practice, when assessing incontinence in
children with CP, sufficiency of cognitive capacity
must also be considered during urodynamic bladder
testing.
In the present study we did not observe any
differences between the NDO and NB groups in terms
of the severity of CP. We also did not observe any
increase in lower urinary system symptoms as the
severity of CP increased. Bross et al. evaluated
urodynamic findings in patients with infantile CP and
correlated the findings with impaired motor function
(22). Symptomatic patients had higher GMFCS levels
than asymptomatic patients. They concluded that
urinary symptoms and pathological urodynamic
findings increase as the degree of motor function
impairment based GMFCS increases.
A limitation of the present study is that only CP
patients with GMFCS levels 3-5 were evaluated, as
children with severe CP usually apply to the pediatric
rehabilitation unit of our hospital. As such, CP
patients with GMFCS level 1 and 2 did not participate
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in the study and we could not examine the
relationship between the severity of CP and lower
urinary system symptoms.
In conclusion, the present study shows that the
incidences of urinary system symptoms and
neurogenic bladder were high in the CP population.
The most frequently observed symptoms were stress
incontinence, and frequency and urgency complaints.
We performed urodynamic examinations in children
with and without lower urinary system symptoms.
Although we observed higher rates of NDO in
subjects with lower urinary system symptoms, we also
observed NDO in asymptomatic subjects. We propose
that the investigation of urinary system symptoms in
all children with CP must be carefully performed and
an urodynamic examination should be performed as
early as possible in children with CP. Urodynamic
examination provides an objectively planned
treatment. We also observed that urinary system
symptoms were not affected by the severity of CP.
Lower IQ levels in the subjects with NDO, although
almost statistically significant, suggest that both
bladder dysfunction and cognitive functions may
influence the achievement of urinary continence in
children with CP.
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